510(k) · Cleared
ClearedTracers TA Bone Cement Opacifier, Model TCR-TA
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Parallax Medical, Inc. · MYU Accessory, Barium Sulfate, Methyl Methacrylate For Cranioplasty
Cleared on Dec 12, 2003 as substantially equivalent to K023445 (Parallax Medical, Inc., 2003) after a 67-day review. Its family tree reaches back 3 generations to 1987.
- Decided
- Dec 12, 2003
- Review
- 67 days
- Class
- Class II
- Product code
- MYU
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 3 generations to K873689 (1987). No later device cites it as a predicate yet.
- Root · 3 generations backK873689 Cranioplastic, Acrylic Cranioplasty MaterialDentsply Intl. · 1987
- 2 generations backK991893 Parallax Tracer Radiopaque ParticlesParallax Medical, Inc. · 1999
- 1 generation backK023445 Tracers Bone Cement OpacifierParallax Medical, Inc. · 2003
- This deviceK033230 Tracers TA Bone Cement Opacifier, Model TCR-TAParallax Medical, Inc. · 2003
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K873689 | Cranioplastic, Acrylic Cranioplasty Material | Dentsply Intl. | 1987 | — |
| −2 | K991893 | Parallax Tracer Radiopaque Particles | Parallax Medical, Inc. | 1999 | — |
| −1 | K023445 | Tracers Bone Cement Opacifier | Parallax Medical, Inc. | 2003 | — |
| 0 (this device) | K033230 | Tracers TA Bone Cement Opacifier, Model TCR-TA | Parallax Medical, Inc. | 2003 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MYU? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K023445 | Tracers Bone Cement OpacifierSummary page 1…MYU D. Predicate Device Identification The subject device is substantially equivalent to TRACERS® Bone Cement Opacifier (K023445). E. Intended Use TRACERS® Ta Bone Cement Op acifier is intended for use as an additive to… | 2003 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 16 years and passes through 2 companies; a new generation was cleared every 3.6 years on median.
- None of the 3 ancestors has a recall.
How does its category compare?
All MYU devicesMYU Accessory, Barium Sulfate, Methyl Methacrylate For Cranioplasty: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MYU
FDA has decided no MYU device since 2007.
Median 510(k) review, days · MYU
Too few MYU 510(k)s in any year since 2007 to give a median.
Recalls per year · MYU
No recall names MYU since 2007.
Adverse event reports per year · MYU
No MAUDE report names MYU since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
TRACERS® Ta Bone Cement Opacifier is intended for use as an additive to Secour TM Acrylic Resin to provide radiopacity for imaging purposes.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K033230 · printed Nov 3, 2026
Cite this page
510(k) Report. “K033230: Tracers TA Bone Cement Opacifier, Model TCR-TA.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K033230
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026